VP 14637 structure
|
Common Name | VP 14637 | ||
---|---|---|---|---|
CAS Number | 235106-62-4 | Molecular Weight | 510.51 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C25H22N10O3 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of VP 14637MDT-637 (VP 14637) is a novel respiratory syncytial virus (RSV) fusion inhibitor with an IC50 of 1.42 ng/mL. |
Name | 2,2''-[(4-HYDROXYFENYL)METHYLEEN]BIS(4-{(E)-[(5-METHYL-1H-TETRAZOOL1-YL)IMINO]METHYL}FENOL) |
---|---|
Synonym | More Synonyms |
Description | MDT-637 (VP 14637) is a novel respiratory syncytial virus (RSV) fusion inhibitor with an IC50 of 1.42 ng/mL. |
---|---|
Related Catalog | |
Target |
IC50: 1.42 ng/mL (RSV)[1] |
In Vitro | MDT‐637 has broad in vitro antiviral activity on clinical strains of different RSV genotypes and clades. MDT-637 inhibits three laboratory strains (RSV-A Long, RSV-A2, and RSV-9320) and four clinical strains (RSV-Memphis-37, RSV-LAP0824, and RSV-HAN1135) with IC50s range from 0.36 to 3.4 ng/mL[1]. |
Cell Assay | The laboratory and clinical isolates of RSV and various concentrations (ranging from 0.1 μM to 31.6 pM) of MDT‐637 (or ribavirin) are added to the HEp-2 cell monolayers at the same time. After 72 hours of incubation at 37°C, the cells and supernatants are harvested. An aliquot is immediately serially diluted and used for plaque assay[1]. |
References |
Molecular Formula | C25H22N10O3 |
---|---|
Molecular Weight | 510.51 |
VP 14637 |